Search Login Register
Angiotensinogen
Summary
1114
relevant articles (9 outcomes,
189 trials/studies)
found for this Bio-Agent
Description:
An alpha-globulin of about 453 amino acids, depending on the species. It is produced by the liver and secreted into blood circulation. Angiotensinogen is the inactive precursor of natural angiotensins. Upon successive enzyme cleavages, angiotensinogen yields angiotensin I, II, and III with amino acids numbered at 10, 8, and 7, respectively.
Also Known As:
Proangiotensin; Renin Substrate Tetradecapeptide; Renin Substrate; Tetradecapeptide, Renin Substrate; Hypertensinogen Show All >>
Key Diseases for which Angiotensinogen is
Relevant
-
Hypertension (High Blood Pressure)
:
3 outcomes 88 studies in 477 results
-
Anoxia (Hypoxia)
:
1 outcome 5 studies in 11 results
-
Inflammation
:
1 outcome 4 studies in 27 results
-
Body Weight (Weight, Body)
:
1 outcome 4 studies in 25 results
-
Obesity
:
1 outcome 2 studies in 37 results
Show All >>
Drugs Related to Angiotensinogen
-
Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)
-
Messenger RNA (mRNA)
-
Angiotensins
-
Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)
-
Renin
-
Endothelins (Endothelin)
-
candesartan
-
eplerenone (Inspra)
-
bosentan (Tracleer)
-
Angiotensin II
Show All >>
Therapies Related to Angiotensinogen
-
Kidney Transplantation
-
Ligation
-
Heart Transplantation (Grafting, Heart)
-
Percutaneous Coronary Transluminal Angioplasty (PTCA)
-
Nephrectomy
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2009 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.